Maintenance of normal maternal thyroxinemia prevents severe triiodothyronine (T3) deficiency of the fetus with primary thyroid failure (1). We have studied whether thyroxine (T4) would also protect the fetal brain when maternal hypothyroxinemia is caused by nonthyroidal illnesses. We have used the streptozotocin-induced diabetes mellitus pregnant rat as a model of maternal nonthyroidal illness. We measured the effects of diabetes mellitus, and of correction of the ensuing maternal hypothyroxinemia with T4 as compared to insulin, on maternal body weight, the outcome of pregnancy, glucose, insulin, T4, T3, reverse T3, and thyrotropin levels in the maternal and fetal circulation, as well as T4 and T3 concentrations in tissues, and iodothyronine deiodinases in liver, lung, and brain. The diabetic mothers showed changes in thyroid hormone status typical of nonthyroidal illnesses. Thyroid hormone status of the fetuses was severely affected: the total T4 and T3 pools decreased to one-third of normal values. T4 and T3 concentrations in the fetal brain were lower than normal and the expected increase in 5'-deiodinase activity was not observed. Although insulin treatment avoided or mitigated these changes, the low cerebral T3 did not improve with T4 treatment of the maternal hypothyroxinemia. Several findings indicated that treatment of the severely ill dams with T4 was actually harmful for the outcome of pregnancy. These negative effects were observed without the expected increase in the maternal or fetal T3 pools.
INTRODUCTION
feet of the maternal T4 would explain the lack of major brain damage of most hypothyroid fetuses at birth, in conTHYROXi NE (T4) and 3,5,3'-triiodothyronine (T3) con-trast with the irreversible central nervous system damage centrations are very low in all tissues of rat fetuses observed in the neurological cretin. The mother of the latfrom dams with methimazole (MMI)-induced primary thy-ter is severely hypothyroxinemic, and does not offer any roid failure. If the maternal hypothyroxinemia is avoided protection to the fetal brain, which is therefore markedly by treatment with T4, the brain is preferentially protected T3 deficient before birth, despite the expected increase in against the deficiency of T3 until birth (1) : fetal brain T3 5'D-II activity (3) . Both in the neurological cretin (4) and reaches normal concentrations, despite lower than normal in the experimental model of rats fed a diet with a very fetal serum T4 and increased TSH levels. T4 is by far the low iodine content (3) , maternal circulating T3 is normal, main source of cerebral T3 in the rat fetus (1, 2) ; changes but this does not improve fetal brain T3 concentrations unin circulating T3 hardly affect cerebral T3 within a physi-less the maternal hypothyroxinemia is also corrected, ological range of serum T3 levels. Both the capacity of cereThese findings have drawn attention to the importance bral type II 5'-iodothyroninedeiodinase (5'D-II) to respond of maintaining normal maternal T4 levels during pregto low fetal serum T4 with a marked increase in its activ-nancy, even when normal T3 levels might prevent the apity and the amount of T4 transferred from the mother to pearance of clinical hypothyroidism. We already cautioned the fetus play crucial roles in maintaining T3 homeostasis (1) , however, against extrapolation of this conclusion to in the brain of the hypothyroid fetus. This protective ef-other situations where changes in maternal and fetal thy- Other determinations rT3 concentrations in maternal and fetal plasma, and in placental extracts, were determined by RIA, as previously described (13, 21) .
Maternal and fetal plasma glucose levels were determined by the glucose oxidase method (22) (Fig. 1) Figure 2 , as well as the circulating % FT4, FT4, % FT3, and FT3. Figure 3 shows the concentrations of T4 and T3 in the liver, lung, brain, heart, and mammary tissue.
Mean concentrations of T4, T3, and rT3 in the maternal circulation and of T4 and T3 in most tissues studied (Figs.
2 and 3) were lower in the D dams as compared to the C mothers, the differences being statistically significant except for M-brain T4 and M-mamma T3. Circulating TSH (Fig. 2) was also lower in the D animals. The circulating % FT4 was increased in the diabetic dams (Fig. 2) (Fig. 4) Effects on thyroid hormone status of the placenta Figure 5 shows the concentrations of T4, T3, and rT3 in the M-and F-placenta. As Effects in the fetus Figure 6 shows the glucose and insulin concentrations in F-plasma, as well as the corresponding T4 and T3 concentrations. F-plasma glucose was markedly elevated, and insulin decreased, in the D progeny. Both were clearly ameliorated by treatment of the mothers with insulin, whereas the infusion of T4 had no effect.
The (Fig. 7) . Treatment of the mothers with insulin usually resulted in improved T4 and T3 concentrations in most F-tissues, as compared to D fetuses, whereas infusion of T4 into the D dams did not improve the low T4 and T3 concentrations of T-tissues, with the exception of a modest increase of F-brain T4.
The 5'D activity in F-liver and F-lung was slightly decreased as compared to C fetuses (Fig. 7) , being restored to normal both with insulin and T4 treatment of the moth- were clearly improved when the mother was treated with insulin. On the contrary, in fetuses from the T4-treated D dams, the changes were different from those observed in the T4 and T3 concentrations of the mothers. Whereas in the mothers plasma and tissues T4 were normal, or higher than normal, the concentrations of T4 in plasma and most tissues of their fetuses are as low as in those of fetuses from D dams, or even lower (i.e., F-plasma T3, Fig. 6 ). In this respect, the changes of the concentrations of T4 in the fetuses from D+T4 dams were similar to those observed for T4 levels in the M-placenta.
There were very good correlations between indices of the fetal and the maternal diabetic state, as assessed both from the circulating glucose and the insulin concentrations. The F-BW ( (5, 6, 10) . At present they are considered as beneficial adaptive responses in situations of limited availability of intracellular energy, when a decrease in T3-dependent catabolic effects is desirable (5) (6) (7) 26) , although this idea is being reconsidered (26) . The two best known mechanisms involved in these responses are a decreased thyroidal secretion of both T4 and T3, which would lower the pool of T4 available for extrathyroidal generation of T3, and a decrease in the activity of enzymes involved in the extrathyroidal generation of T3 from T4.
The sequence of events leading to the first of these mechanisms appears to involve decreased release of hypothalamic TRH (27) (28) (29) , decreased secretion of TSH (27) (28) (30) (31) (32) (33) , and a decreased sensitivity of the thyroid to TSH (32) . The normal feedback mechanism is superseded, and TSH levels actually decrease, despite the lower levels of circulating total and/or free T4 and T3. Indeed, a return to normal secretion of TSH, accompanied by normalization of the thyroidal release of hormones, is considered as an index that the illness is remitting, or that the metabolic alterations are under control. In the nonpregnant rat with STZ-induced diabetes mellitus these mechanisms are fully operative, and the decreased thyroidal production of the iodothyronines is quantitative very important (10) .
In the present study diabetes mellitus was induced during pregnancy. The changes in circulating total and free T4 and T3, together with decreased TSH, and the low T4 and T3 levels found in all the tissues studied in the present D dams are in agreement with the changes described for the nonpregnant diabetic rats (10) , and for patients dying from different nonthyroidal illnesses (34) , indicating that 2 weeks after the injection of STZ, the adaptive mechanisms involving decreased thyroidal secretion of thyroid hormones are fully operative.
With respect to the second mechanism, the direct measure of 5'D-I activities in the liver and lung of the pregnant D rats of the present study has confirmed that generation of T3 from T4 is decreased. Such a decrease was also previously described for both nonpregnant (9, 35, 36) and pregnant (11) Although treatment with T3 has been recently found to be beneficial after coronary artery bypass surgery (38, 39) , it is suspected that treatment with T4 is of no benefit to patients with nonthyroidal illness (40, 41 
